“…Two stabiliz-129 ers, an amphiphilic diblock copolymer (i.e., PEG-PLA 2-8 k) plus a 130 co-stabilizer (i.e., PVP), were found necessary to maintain the sta-131 bility of the CUR nanoparticles during subsequent processing treat-132 ments (i.e., dialysis and freeze drying). Further work comparing the 133 relative performance of a CIJ-D-M and an MIVM also indicated that 134 while good particle size control could be achieved with either 135 mixer, the stability of the preparation in the presence of copolymer 136 stabilizer alone could not last for more than a few hours even with 137 some process optimization [22]. It should be reiterated that our 138 choice of CUR in this previous work was guided by it having a 139 log P value ($3) typical of most drugs and its wide array of proven 140 pharmacological activities (e.g., anti-oxidative, anti-inflammatory, 141 cholesterol-lowering, anti-amyloid, and anti-cancer activities), 142 which may be beneficial to the treatment of Alzheimer's disease 143 and cancers [23,24].…”